UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

BMC neurology, 2020-07, Vol.20 (1), p.281-281, Article 281

2020

Volltextzugriff (PDF)

Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants

Alzheimer's research & therapy, 2024-02, Vol.16 (1), p.25-25, Article 25

2024

Volltextzugriff (PDF)

Addressing Health-Care System Inequities in the Management of Erectile Dysfunction: A Call to Action

American journal of men's health, 2020-09, Vol.14 (5), p.155798832096507-1557988320965078

2020

Volltextzugriff (PDF)

Pregnancy rates and outcomes in women with and without MS in the United States

Neurology, 2018-10, Vol.91 (17), p.e1559

2018

Volltextzugriff (PDF)

Artificial Intelligence in Endourology: Maximizing the Promise Through Consideration of the Principles of Diffusion of Innovation Theory

Journal of endourology, 2024-08, Vol.38 (8), p.755-762

2024

Volltextzugriff (PDF)

Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus

Journal of neurosurgery, 2015-01, Vol.122 (1), p.139-147

2015

Volltextzugriff (PDF)

Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal

Journal of cerebral blood flow and metabolism, 2024-01, Vol.44 (1), p.131-141

2024

Volltextzugriff (PDF)

The Epidemic of COVID-19-Related Erectile Dysfunction: A Scoping Review and Health Care Perspective

Sexual medicine reviews, 2022-04, Vol.10 (2), p.286-310

2022

Volltextzugriff (PDF)

Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database

Multiple sclerosis and related disorders, 2020-11, Vol.46, p.102541-102541, Article 102541

2020

Volltextzugriff (PDF)

Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review

International journal of MS care, 2023-09, Vol.25 (5), p.188-195

2023

Volltextzugriff (PDF)

Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis

Current medical research and opinion, 2018-08, Vol.34 (8), p.1389-1395

2018

Volltextzugriff (PDF)

Comorbidity in US patients with multiple sclerosis

Patient related outcome measures, 2018-01, Vol.9, p.97-102

2018

Volltextzugriff (PDF)

Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapy

Multiple sclerosis journal - experimental, translational and clinical, 2022-04, Vol.8 (2), p.205521732211011-20552173221101150

2022

Volltextzugriff (PDF)

The Role of Decision Analytic Modeling in the Health Economic Assessment of Spinal Intervention

Spine (Philadelphia, Pa. 1976), 2014-10, Vol.39 (22S Suppl 1), p.S16-S42

2014

Volltextzugriff (PDF)

A pathway linking pulse pressure to dementia in adults with Down syndrome

Brain communications, 2024, Vol.6 (3), p.fcae157

2024

Volltextzugriff (PDF)

The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving

Journal of medical economics, 2012-08, Vol.15 (4), p.623-634

2012

Volltextzugriff (PDF)

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia

Current medical research and opinion, 2008-12, Vol.24 (12), p.3341-3355

2008

Volltextzugriff (PDF)

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA

PharmacoEconomics, 2005-01, Vol.23 Suppl 1 (S1), p.75-89

2005

Volltextzugriff (PDF)

Gaps in treatment and treatment discontinuation among patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying drugs (P3.2-102)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Cerebrovascular features of Alzheimer’s disease in adults with Down syndrome

Alzheimer's & dementia, 2023-12, Vol.19 (S12), p.n/a

2023

Volltextzugriff (PDF)

Cost-effectiveness model of long-acting risperidone in schizophrenia in the US

PharmacoEconomics, 2005-01, Vol.23 (3), p.299-314

2005

Volltextzugriff (PDF)

Meta-analysis of real-world adherence and persistence of maintenance once- or twice-daily oral disease-modifying drugs (dimethyl fumarate, fingolimod, and teriflunomide) in multiple sclerosis (P3.2-041)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Multiple Sclerosis Relapse Rates, Before, During, and After Pregnancy: a US Retrospective Claims Database Analysis (P1.361)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Pseudo‐longitudinal trajectories of cerebrovascular disease biomarkers in adults with Down syndrome across the lifespan

Alzheimer's & dementia, 2023-12, Vol.19 (S10), p.n/a

2023

Volltextzugriff (PDF)

Pseudo‐longitudinal trajectories of cerebrovascular disease biomarkers in adults with Down syndrome across the lifespan

Alzheimer's & dementia, 2023-12, Vol.19 (S13), p.n/a

2023

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants

Addressing Health-Care System Inequities in the Management of Erectile Dysfunction: A Call to Action

Pregnancy rates and outcomes in women with and without MS in the United States

Artificial Intelligence in Endourology: Maximizing the Promise Through Consideration of the Principles of Diffusion of Innovation Theory

Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus

Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal

The Epidemic of COVID-19-Related Erectile Dysfunction: A Scoping Review and Health Care Perspective

Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database

Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review

Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis

Comorbidity in US patients with multiple sclerosis

Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapy

The Role of Decision Analytic Modeling in the Health Economic Assessment of Spinal Intervention

A pathway linking pulse pressure to dementia in adults with Down syndrome

The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia

Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA

Gaps in treatment and treatment discontinuation among patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying drugs (P3.2-102)

Cerebrovascular features of Alzheimer’s disease in adults with Down syndrome

Cost-effectiveness model of long-acting risperidone in schizophrenia in the US

Meta-analysis of real-world adherence and persistence of maintenance once- or twice-daily oral disease-modifying drugs (dimethyl fumarate, fingolimod, and teriflunomide) in multiple sclerosis (P3.2-041)

Multiple Sclerosis Relapse Rates, Before, During, and After Pregnancy: a US Retrospective Claims Database Analysis (P1.361)

Pseudo‐longitudinal trajectories of cerebrovascular disease biomarkers in adults with Down syndrome across the lifespan

Pseudo‐longitudinal trajectories of cerebrovascular disease biomarkers in adults with Down syndrome across the lifespan

Suchergebnisse filtern